Condition
    Moderate Evidence
    Effectiveness 4/5

    Melatonin for Traumatic Brain Injury

    Sleep disruption is one of the strongest predictors of prolonged concussion symptoms, and melatonin has randomised evidence for improving it after brain injury.

    Overview

    Sleep disruption is one of the strongest predictors of prolonged concussion symptoms, and melatonin has randomised evidence for improving sleep quality after mild to moderate traumatic brain injury. That is the claim, and it is a narrower one than it first appears. Brain injury disrupts circadian melatonin secretion, and pineal output is measurably reduced after traumatic injury. Restoring the signal is a targeted correction, not a general neuroprotective play.
    Trials measured sleep quality, fatigue and anxiety after TBI, not recovery of the brain injury itself. A paediatric concussion trial found no reduction in symptom scores, so do not expect melatonin to shorten recovery in someone who is already sleeping normally. It is also not a substitute for treating post-traumatic headache or vestibular dysfunction.

    Best suited to

    Disrupted sleep after mild to moderate TBI
    Post-injury circadian misalignment
    Fatigue driven by poor sleep
    Use alongside a rehabilitation programme
    Not for normal sleep after concussion
    Not a treatment for the injury itself

    How It Works

    Exogenous melatonin acts on MT1 and MT2 receptors in the suprachiasmatic nucleus, advancing sleep onset and helping consolidate sleep architecture. After traumatic brain injury the pineal signal is blunted, so supplementation is closer to replacement than to sedation. This distinction matters clinically. Melatonin is a timing signal, not a hypnotic, which is why dose escalation rarely helps and why timing relative to desired sleep onset does most of the work.
    Sleep is when glymphatic clearance and synaptic consolidation are most active, and poor sleep amplifies headache, cognitive fog, irritability and mood symptoms. Improving sleep after TBI may therefore improve the symptom burden without altering the underlying injury trajectory, which is consistent with what the trials measured.

    Mechanistic steps

    Reduced pineal output after injury
    MT1 and MT2 receptor activation
    Suprachiasmatic nucleus signalling
    Advanced sleep onset
    Consolidated sleep architecture
    Reduced fatigue and anxiety

    Dosing & Protocol

    ScenarioDoseFormTiming
    Trial protocol2 mgProlonged-release melatoninOne hour before bed
    Upper studied doseUp to 5 mgProlonged or immediate release30-60 minutes before bed
    Circadian shifting0.5-1 mgImmediate releaseSeveral hours before desired sleep onset
    Duration4 weeks then reassess--
    1. 1

      Involve the rehabilitation team· Before starting

      Post-TBI sleep problems have several possible causes. Melatonin should sit inside a managed recovery plan, not outside it.

    2. 2

      Start 2 mg prolonged-release an hour before bed· Weeks 1-2

      This is the formulation and dose used in the post-TBI sleep trials.

    3. 3

      Fix sleep timing and light exposure· Ongoing

      Consistent wake time and morning daylight do more for circadian realignment than the tablet does.

    4. 4

      Do not escalate independently· Ongoing

      Some trials used up to 5 mg, but higher doses mainly increase grogginess and vivid dreams.

    5. 5

      Reassess at four weeks· Week 4

      If sleep has not improved, look for post-traumatic headache, sleep apnoea, mood disorder or medication effects.

    Melatonin availability varies by country. In the UK and much of Europe prolonged-release melatonin is a prescription medicine, which in this context is an advantage: post-TBI care should be supervised, and a prescriber can check it against the rest of the recovery plan.

    Timing beats dose

    Melatonin is a circadian signal. Taking 2 mg consistently an hour before a fixed bedtime outperforms taking a larger dose at a variable time.

    Evidence

    Randomised trials in adults with mild to moderate TBI report improved sleep quality, reduced fatigue and lower anxiety with prolonged-release melatonin over about four weeks. The effect on sleep is the consistent finding. The counterweight is a paediatric concussion trial that found no reduction in symptom scores, which is a useful corrective against overclaiming. Sample sizes are small across the literature, and no trial demonstrates altered recovery of the injury itself. No individual trials are linked to this pairing in our database yet.
    Best available evidence
    Randomised trials of prolonged-release melatonin after mild to moderate TBI
    Typical effect
    Improved sleep quality, reduced fatigue and anxiety
    No demonstrated effect on
    Concussion symptom scores in children, or injury recovery itself
    Studied dose
    2 mg prolonged-release, up to 5 mg
    Certainty of evidence
    Moderate for sleep, low for symptom recovery

    No studies are yet linked to both Melatonin and Traumatic Brain Injury.

    Safety

    Melatonin is well tolerated at these doses. Morning grogginess and vivid dreams are the usual complaints, and both tend to ease with a lower dose or earlier timing. After brain injury there is an additional consideration: fatigue, slowed processing and daytime drowsiness are already common, so anything that adds sedation should be monitored by the clinical team rather than self-titrated.

    Seek urgent care for deterioration

    Worsening headache, repeated vomiting, new weakness, seizures, confusion or increasing drowsiness after a head injury are emergencies. Do not attribute them to a supplement.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Fluvoxamine
    high
    		CYP1A2 inhibition sharply raises melatonin levelsAvoid the combination
    Warfarin
    moderate
    		Reported effects on bleeding riskMonitor INR when starting or stopping
    Sedatives and benzodiazepines
    moderate
    		Additive drowsiness on top of post-injury fatigueUse only under clinical supervision
    Antiepileptic medication
    moderate
    		Reported interactions in both directions after brain injuryDiscuss with the treating neurologist
    Melatonin does not replace the rest of concussion management. Graded return to activity, consistent sleep-wake timing, daylight exposure, and treatment of post-traumatic headache and vestibular dysfunction all have stronger claims on your attention. Use melatonin as one component within that plan.

    References

    1. Randomised controlled trials of prolonged-release melatonin for sleep disturbance after traumatic brain injury
    2. Randomised trial of melatonin for persistent post-concussive symptoms in children
    3. Consensus statement on concussion in sport and clinical guidance on post-injury sleep management

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.